Skip to content

Public FDA record

Z-0815-2021: NaturaLyte Liquid Acid concentrate bottles, Model Number 08-2251-0 - Product Usage: used in conjunction w

Recall record Z-0815-2021 for Fresenius Medical Care Holdings, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0815-2021
Company in FDA record
Fresenius Medical Care Holdings, Inc.
FDA classification date
Jan 11, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The sodium and/or calcium levels in these concentrates were below the manufacturing specifications.

Source facts

Action
An URGENT MEDICAL DEVICE ALERT dated 11/7/20 was sent to customers. If you are in possession of the impacted product, it is recommended that all alternative options be explored prior to using this product. This includes determining if nonimpacted FMCRTG, LLC lots are available or using alternative suppliers of liquid acid product. This issue only impacts the list of lots provided- no other lots are affected. At this time, we are working with the FDA to determine appropriate next steps. Please note that we are currently experiencing a disruption in our supply, which may impact our ability to distribute non-impacted product. We apologize for any inconvenience. Please contact Fresenius Medical Care Customer Services team at 1-800-323-5188 if you have unique circumstances or an urgent need concerning product delivery. Please contact our Medical Information team at 1-855-616-2309 to discuss any medical or scientific questions you may have. We will provide updates as soon as we have additional information. The health and safety of our patients continue to be our highest priority. Thank you for your cooperation. An additional URGENT MEDICAL DEVICE ALERT dated 11/14/20 was sent to customers. If you currently have or receive impacted product: 1. It is still recommended that all alternative options be explored prior to using this product. This includes the use of non-impacted product from FMCRTG, LLC or similar products from alternate suppliers. 2. Impacted product that is released by FMCRTG, LLC will be clearly marked with Low Sodium at the case level. 3. Use the attached impacted lot list to clearly identify all impacted product in your facility. 4. Mark or tag all impacted product so that any potential user can distinguish between impacted and non-impacted product. 5. Should your facility need to use an impacted product, you must notify your prescribing physicians that dialysis prescription adjustments may be necessary in order to safely use the impacte
Initiated
2020-11-07
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution.
Recall number
Z-0815-2021
Recall status
Open, Classified
CDRH record ID
184694
FDA classified
2021-01-11
Recall event number
86855

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗